AUDENTES THERAPEUTICS INC's ticker is BOLD and the CUSIP is 05070R104.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $44,609,000 | -31.2% | 1,588,069 | -7.3% | 0.85% | -15.7% |
| Q2 2019 | $64,857,000 | -8.4% | 1,713,069 | -5.6% | 1.00% | -8.4% |
| Q1 2019 | $70,821,000 | +75.4% | 1,815,000 | -4.1% | 1.10% | +46.9% |
| Q4 2018 | $40,369,000 | -53.2% | 1,893,500 | -13.1% | 0.75% | -28.3% |
| Q3 2018 | $86,306,000 | -13.6% | 2,180,000 | -16.6% | 1.04% | -12.8% |
| Q2 2018 | $99,919,000 | -5.6% | 2,615,000 | -25.8% | 1.19% | -9.1% |
| Q1 2018 | $105,839,000 | -18.0% | 3,522,100 | -14.7% | 1.31% | -19.6% |
| Q4 2017 | $129,051,000 | +11.6% | 4,129,638 | 0.0% | 1.63% | +47.7% |
| Q3 2017 | $115,671,000 | +25.9% | 4,129,638 | -14.0% | 1.10% | +14.7% |
| Q2 2017 | $91,855,000 | +12.3% | 4,801,638 | 0.0% | 0.96% | +3.9% |
| Q1 2017 | $81,820,000 | -6.7% | 4,801,638 | 0.0% | 0.93% | -17.1% |
| Q4 2016 | $87,726,000 | +2.6% | 4,801,638 | 0.0% | 1.12% | +14.8% |
| Q3 2016 | $85,517,000 | – | 4,801,638 | – | 0.97% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 250,620 | $9,779,000 | 11.87% |
| Versant Venture Management, LLC | 803,106 | $31,337,196,000 | 10.32% |
| GREAT POINT PARTNERS LLC | 1,572,618 | $61,364,000 | 6.07% |
| Casdin Capital, LLC | 1,010,000 | $39,410,000 | 4.33% |
| Sofinnova Investments, Inc. | 933,640 | $36,431,000 | 3.51% |
| Foresite Capital Management III, LLC | 315,331 | $12,304,000 | 3.20% |
| Redmile Group, LLC | 2,735,267 | $106,730,000 | 3.12% |
| Opaleye Management Inc. | 280,000 | $10,926,000 | 3.02% |
| Global Endowment Management, LP | 391,581 | $15,279,000 | 2.16% |
| Ghost Tree Capital, LLC | 175,000 | $6,829,000 | 1.78% |